Differential induction of cyclooxygenase-2 in human arterial and venous smooth muscle: Role of endogenous prostanoids

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 18, Issue 10, 1998, Pages 1655-1661

  Bishop Bailey, David ^a   Pepper, John R ^b   Larkin, Simon W ^a   Mitchell, Jane A ^b  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

Atherosclerosis; Coronary artery bypass grafting; Internal mammary artery; Saphenous vein

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; GAMMA INTERFERON; INTERLEUKIN 1; PROSTAGLANDIN E2; PROSTANOID; TUMOR NECROSIS FACTOR ALPHA;

ARTERY MUSCLE; ARTICLE; ATHEROSCLEROSIS; CORONARY ARTERY BYPASS GRAFT; ENZYME ACTIVITY; ENZYME INDUCTION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; INTERNAL MAMMARY ARTERY; PRIORITY JOURNAL; PROSTAGLANDIN RELEASE; PROTEIN EXPRESSION; SAPHENOUS VEIN;

EID: 0031718390     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.18.10.1655     Document Type: Article

References (15)

1. Smith WL, Garavito RM, DeWitt DL. Prostaglandin endoperoxide H synthases (cyclo-oxygenases)-1 and -2. J Biol Chem. 1996;271: 33157-33160.
2. Moncada S, Gryglewski R, Bunting S, Vane JR. An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation. Nature. 1976;263:663-665.
3. Coleman RA, Smith WL, Narumiya S. International Union of Pharmacology classification of prostanoid receptors: properties, distribution of the receptors and their subtypes. Pharmacol Rev. 1994;46:205-229.
4. Hajjar DP, Pomerantz KB. Signal transduction in atherosclerosis: integration of cytokines and the eicosanoid network. FASEB J. 1992;6: 2933-2941.
5. Hara S, Morishita R, Tone Y, Yokoyama C, Inoue H, Kaneda Y, Tanabe T. Overexpression of prostacyclin symhase inhibits growth of vascular smooth muscle cells. Biochem Biophys Res Commun. 1995;216:862-867.
6. Smith WL. Prostaglandin synthesis and its compartmentation in vascular smooth muscle and endothelial cells. Annu Rev Physiol. 1986;48: 251-262.
7. Mitchell JA, Akarasereenont P, Thiemermann C, Flower RJ, Vane JR. Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase. Proc Natl Acad Sci USA. 1993; 90:11693-11697.
8. Xie W, Chipman JG, Robertson DL, Erikson RL, Simmons DL. Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing. Proc Natl Acad Sci USA. 1991;88:2692-2696.
9. Kujubu DA, Fletcher BS, Varum BC, Lim RW, Herschman HR. TIS10, a phorbol ester tumour promoter-irtducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue. J Biol Chem. 1991;266:12866-12872.
10. Hla T, Nielson K. Human cyclo-oxygenase-2 cDNA. Proc Natl Acad Sci USA. 1992;89:7384-7388.
11. 2 synthase (cyclooxygenase) in human monocytes. J Biol Chem. 1990;265:16737-16740.
12. Mitchell JA, Belvisi M, Akarasereenont P, Robbins R, Kwon O-J, Croxtall J, Barnes PJ, Vane JR. Induction of cyclo-oxygenase-2 by cytokines in human pulmonary epithelial cells: regulation by dexamelhasone. Br J Pharmacol. 1994;113:1008-1014.
13. Belvisi MG, Saunders MA, Haddad E-B, Hirst S-J, Yacoub MH, Barnes PJ, Mitchell JA. Induction of cyclo-oxygenase-2 by cytokines in human cultured airway smooth muscle cells: novel inflammatory role of this cell type. Br J Phamacol. 1997;120:910-916.
14. Crofford LJ, Wilder RL, Ristimaki AP, Sano H, Remmers EF, Epps HR, Hla T. Cyclo-oxygenase-1, and -2 expression in rheumatoid synovial tissues: effects of interleukin-1β, phorbol ester, and corticosteroids. J Clin Invest. 1994;93:1095-1101.
15. Vane JR, Mitchell JA, Appleton I, Tomlinson A, Bishop-Bailey D, Croxtall J, Willoughby DA. Inducible isoforms of cyclooxygenase and nitric oxide synthase in inflammation. Proc Natl Acad Sci USA. 1994; 91:2046-2050.